69 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
, or instability from an outbreak of pandemic or contagious disease, such as the novel coronavirus (COVID-19), or surrounding the duration and severity
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
or of any other Party), act of God, war, riot, civil commotion, malicious damage, pandemic, compliance with any Applicable Law coming into effect after
8-K
EX-99.1
4gg96yzfoq20
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
8-K/A
EX-99.1
o0j5x8
6 Mar 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:07pm
8-K
EX-99.1
vgqyo osqc1d1wsega5n
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm
8-K
EX-99.1
kxg69lz4u8ybs3rss
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
EX-99.1
iiy94bhpe7x 6jt
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-99.1
bbf6vel
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
lpqyg
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
fk0nsp6m v6qx6ij87
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
EX-99.1
0am3s50efripv 7g
6 Jun 23
Other Events
5:39pm
8-K
EX-99.1
55fpcq8 7ovfz2
4 Apr 23
Other Events
12:32pm